Poly(ortho ester) nanoparticles targeted for chronic intraocular diseases: ocular safety and localization after intravitreal injection

Nanotherapies for the treatment of ocular diseases

(2015) S. Reimondez-Troitiño et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Novel Endogenous Glycan Therapy for Retinal Diseases: Safety, In Vitro Stability, Ocular Pharmacokinetic Modeling, and Biodistribution

(2014) Shankar Swaminathan et al.   AAPS Journal

Nanotherapy for posterior eye diseases

(2014) Indu Pal Kaur et al.   JOURNAL OF CONTROLLED RELEASE

Synthesis, characterization and in vitro studies of celecoxib-loaded poly(ortho ester) nanoparticles targeted for intraocular drug delivery

(2013) Mallika Palamoor et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Nanomedicines for back of the eye drug delivery, gene delivery, and imaging

(2013) Uday B. Kompella et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Poly(ortho ester) Nanoparticle-Based Targeted Intraocular Therapy for Controlled Release of Hydrophilic Molecules

(2012) Mallika Palamoor et al.   MOLECULAR PHARMACEUTICS

Chitosan Coated PLA Nanoparticles for Ophthalmic Delivery: Characterization,In-Vitro and In-Vivo Study in Rabbit Eye

(2011) Ramesh C. Nagarwal et al.   Journal of Biomedical Nanotechnology

Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents

(2011) Chirag P. Shah et al.   OPHTHALMOLOGY

Applications of nanoparticles in ophthalmology

(2010) Yolanda Diebold et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Polymeric nanoparticulate system: A potential approach for ocular drug delivery

(2009) Ramesh C. Nagarwal et al.   JOURNAL OF CONTROLLED RELEASE

Current and future ophthalmic drug delivery systemsA shift to the posterior segment

(2008) E DELAMO et al.   DRUG DISCOVERY TODAY

Safety Evaluation of Ocular Drug Delivery Formulations: Techniques and Practical Considerations

(2008) Brian G. Short   TOXICOLOGIC PATHOLOGY